Series date: 
01/01/2023 - 12:00pm to 12/31/2023 - 1:00pm

LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:

  • Summarize latest findings in literature related to areas of Nephrology, Hypertension, Kidney and Pancreas transplant 
  • Critique the presented findings in term of strengths, weaknesses and generalizability
  • Describe how these findings may alter current practices in Nephrology and Hypertension 
 

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.


Credit Statement(s):
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ANCC
Mayo Clinic College of Medicine and Science designates this activity for a maximum of 1.00 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

AAPA
Mayo Clinic College of Medicine and Science has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

 
DISCLOSURE SUMMARY
As a provider accredited by Joint Accreditation for Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities.  All who are in a position to control the content are required to disclose all financial relationships with any ineligible company.   Faculty will also identify any off-label and/or investigational use of pharmaceuticals or instruments discussed in their content for FDA compliance.
 

Listed below are individuals with control of the content of this program who have disclosed…

Relevant financial relationship(s) with ineligible companies:
Musab Hommos, MBBS - Share Stockholder - Abbvie, Johnson & Johnson, CorMedix, Syros Pharma, Checkpoint therapeutics, Theriva, Biologics, Sorrento therapeutics. All publicly traded companies

All relevant financial relationships have been mitigated. 
 
No relevant financial relationship(s) with ineligible companies:
Sumi Nair, MBBS, M.D.    
Danieille E. Akin, P.A.-C. 
Elisa Marciano-Holohan                                                    
Ian Paul Rios, APRN, D.N.P.
Senaida Behmen, APRN
 
References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
None
 
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here.
 
ATTENDANCE/CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance.  All learners are encouraged to text attendance regardless of credit needs.  This number is only used for receiving text messages related to tracking attendance.  Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.
 
COURSE DIRECTOR
Musab Hommos, MBBS
 
Support location: 
Arizona

Sessions

Session Date
Personalized Cooler Dialysate for patients receiving maintenance hemodialysis (MyTEMP): a pragmatic, cluster randomized trial. 02/15/2023 - 12:00pm to 1:00pm
Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure. The TRANSFORM-HF Randomized Clinical Trial 03/01/2023 - 12:00pm to 1:00pm
Sips and CYPs: Association of CYPA12 genotype and caffeine intake on renal dysfunction. 04/05/2023 - 12:00pm to 1:00pm
Title: The Effect of Magnesium Supplementation on Vascular Calcification in Chronic Kidney Disease: A Randomized Clinical Trial (MAGiCAL-CKD) 04/19/2023 - 12:00pm to 1:00pm
Immune Checkpoint Molecule TIGIT Regulates Kidney T Cell Functions and Contributes to AKI 05/03/2023 - 12:00pm to 1:00pm
Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence 05/17/2023 - 12:00pm to 1:00pm
Associations Between Ambient Extreme Heat Exposure and Emergency Department Visits Related to Kidney Disease 06/07/2023 - 12:00pm to 1:00pm
Immuno-guided Discontinuation of Prophylaxis for CMV Disease in Kidney Transplant Recipients treated with Antithymocyte Globulin: A Randomized Clinical Trial 08/16/2023 - 12:00pm to 1:00pm
An evaluation of a recent article that evaluated whether sodium bicarbonate treatment in patients with chronic kidney disease will promote vascular function 09/06/2023 - 12:00pm to 1:00pm
Pregnancy after living kidney donation, a systematic review of the available evidence, and a review of the current guidance 09/20/2023 - 12:00pm to 1:00pm

Pages